Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy
Ophthalmology Retina · 2026-01 · 10 (1) · 81-87
DOI: 10.1016/j.oret.2025.06.014 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift Ophthalmology Retina, 2026-01. Verfasst von Abhiram R Manda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Medicine, Nashville, Tennessee. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Interleukin-6, Aqueous Humor, Visual Acuity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Eye Institute, Research to Prevent Blindness.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt University School of Medicine, Nashville, Tennessee.
- Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee.
- Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: stephen.j.kim@vumc.org.
Förderung
- NEI NIH HHS
- National Eye Institute
- Research to Prevent Blindness
Zitieren
APA
Manda, A. R., Lee, L. H., Steinkerchner, M. S., Sheng, J., Veach, L., Gangaputra, S., & Kim, S. J. (2026). Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy. Ophthalmology Retina, 10(1), 81-87. https://doi.org/10.1016/j.oret.2025.06.014
Vancouver
Manda AR, Lee LH, Steinkerchner MS, Sheng J, Veach L, Gangaputra S, et al. Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy. Ophthalmology Retina. 2026;10(1):81-87. doi:10.1016/j.oret.2025.06.014
BibTeX
@article{Manda2026,
author = {Manda, Abhiram R and Lee, Lok Hin and Steinkerchner, Megan S and Sheng, Jinsong and Veach, Lindsay and Gangaputra, Sapna and Kim, Stephen J},
title = {Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy},
journal = {Ophthalmology Retina},
year = {2026},
volume = {10},
number = {1},
pages = {81--87},
doi = {10.1016/j.oret.2025.06.014}
}
EUVIMED